Profitability
by Company within Major Pharmaceutical Preparations Industry
|
Company |
Quarter |
Gross Margin |
Net Margin |
Cash flow Margin |
ROE |
Abcellera Biologics Inc |
1 Q |
- |
53.25% |
22.27% |
19.72% |
Abeona Therapeutics Inc |
1 Q |
- |
-6008.96% |
-3645.09% |
-145.51% |
Abbott Laboratories |
1 Q |
58.07% |
20.57% |
-17.86% |
22.02% |
Arbutus Biopharma Corp |
1 Q |
- |
-125.31% |
-222.18% |
-53.43% |
Abvc Biopharma Inc. |
1 Q |
92.61% |
-23724.14% |
-12208.21% |
-294.28% |
Acadia Pharmaceuticals Inc |
1 Q |
97.45% |
-97.91% |
49.78% |
-40.52% |
Acer Therapeutics Inc. |
1 Q |
- |
- |
- |
- |
Acelrx Pharmaceuticals Inc |
1 Q |
-77.38% |
-1962.44% |
- |
- |
Acura Pharmaceuticals inc |
3 Q |
- |
-97.04% |
-28.89% |
- |
Acurx Pharmaceuticals inc |
1 Q |
- |
- |
- |
- |
Adc Therapeutics Sa |
4 Q |
95.89% |
-678.2% |
- |
-138.5% |
Adial Pharmaceuticals Inc. |
1 Q |
- |
- |
- |
-232.78% |
Adamis Pharmaceuticals Corp |
1 Q |
-26.77% |
-896.88% |
-472.32% |
-132.77% |
Adamas Pharmaceuticals Inc |
3 Q |
97.78% |
-75.37% |
-39.29% |
- |
Aditxt Inc. |
1 Q |
10.56% |
-2881.48% |
-2737.72% |
-71.62% |
Advaxis Inc. |
1 Q |
- |
-976% |
-3858% |
-29.54% |
Aeterna Zentaris Inc |
4 Q |
98.29% |
-159.09% |
- |
-15.79% |
Affimed N v |
4 Q |
- |
-142.5% |
- |
-42.31% |
Agex Therapeutics Inc |
4 Q |
96.3% |
-7996.3% |
-114.81% |
- |
Agios Pharmaceuticals Inc |
1 Q |
59.25% |
-11391.11% |
-14795.67% |
-25.95% |
Aeglea Biotherapeutics Inc |
1 Q |
- |
-1794.13% |
-37.81% |
-78.56% |
Agile Therapeutics Inc |
1 Q |
13.29% |
-668.31% |
-874.5% |
-588% |
Aimmune Therapeutics Inc |
2 Q |
- |
- |
- |
-170.95% |
Akebia Therapeutics Inc |
1 Q |
49.2% |
-101.17% |
41.83% |
-266.13% |
Akcea Therapeutics Inc |
2 Q |
93.66% |
-221.55% |
-123.23% |
-8.94% |
Akero Therapeutics Inc |
1 Q |
- |
- |
- |
-60.85% |
Akorn Inc |
2 Q |
25.81% |
-57.07% |
9.11% |
-62.97% |
Akari Therapeutics Plc |
4 Q |
- |
- |
- |
-185.67% |
Akouos inc |
1 Q |
- |
- |
- |
-40.01% |
Albireo Pharma inc. |
1 Q |
96.57% |
-621.11% |
-460.36% |
-21.15% |
Aldeyra Therapeutics Inc |
1 Q |
- |
- |
- |
-29.78% |
Alimera Sciences Inc |
1 Q |
85.88% |
-50.05% |
-55.18% |
- |
Alkermes Plc |
1 Q |
80.2% |
-12.89% |
-19.74% |
-5.63% |
Allakos Inc |
1 Q |
- |
- |
- |
-91.36% |
Allogene Therapeutics Inc |
1 Q |
- |
-130901.64% |
-145573.77% |
-32.28% |
Alnylam Pharmaceuticals Inc |
1 Q |
89% |
-112.7% |
-134.06% |
-137.44% |
Alpine Immune Sciences Inc |
1 Q |
- |
-55.23% |
-242.26% |
-46.87% |
Alexion Pharmaceuticals Inc |
1 Q |
92.34% |
29.89% |
28.84% |
4.69% |
Alx Oncology Holdings Inc |
1 Q |
- |
- |
- |
-25.07% |
Alzamend Neuro Inc |
4 Q |
- |
- |
- |
- |
Amag Pharmaceuticals inc |
3 Q |
85.67% |
20.78% |
-0.58% |
-69.3% |
Ampio Pharmaceuticals inc. |
1 Q |
- |
- |
- |
-87.38% |
Amphastar Pharmaceuticals Inc |
1 Q |
46.38% |
20.15% |
38.44% |
18.35% |
Amarin Corp Plcuk |
1 Q |
76.5% |
-33.35% |
-0.32% |
-3.42% |
Amneal Pharmaceuticals Inc |
1 Q |
35.08% |
-1.3% |
-8.08% |
-0.22% |
Applied Molecular Transport Inc |
1 Q |
- |
- |
- |
-71.26% |
Anaptysbio inc |
1 Q |
- |
-3737.63% |
-33950.21% |
-20.84% |
Arctos Northstar Acquisition Corp. |
1 Q |
- |
- |
- |
- |
Anebulo Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
Ani Pharmaceuticals inc |
1 Q |
46.85% |
-31.22% |
-36.28% |
-24.05% |
Anixa Biosciences Inc. |
1 Q |
- |
- |
- |
-37.37% |
Annexon Inc |
1 Q |
- |
- |
- |
-56.31% |
Annovis Bio inc |
1 Q |
- |
- |
- |
-37.83% |
Apellis Pharmaceuticals Inc |
1 Q |
- |
-966.1% |
-46.87% |
-607.37% |
Applied Therapeutics Inc |
1 Q |
- |
- |
- |
-137.7% |
Aptinyx Inc |
1 Q |
- |
- |
- |
-77.57% |
Aquestive Therapeutics Inc |
1 Q |
65.66% |
-107.74% |
-108.3% |
- |
Aravive Inc |
1 Q |
- |
-1195.7% |
- |
-88.49% |
Arcturus Therapeutics Holdings Inc |
1 Q |
- |
-975.76% |
-968.99% |
-81.21% |
Aridis Pharmaceuticals inc. |
1 Q |
- |
-654.25% |
-483.91% |
- |
Ardelyx inc |
1 Q |
81.84% |
-5998.08% |
-5416.88% |
-177.07% |
Arena Pharmaceuticals Inc |
4 Q |
- |
-288164.81% |
-300150% |
-69.83% |
Arcutis Biotherapeutics Inc |
1 Q |
- |
- |
- |
-70.62% |
Array Technologies Inc |
1 Q |
8.85% |
-7.34% |
-105.85% |
- |
Arvinas Inc |
1 Q |
- |
-18.6% |
-190.08% |
-21.27% |
Ascendis Pharma A |
4 Q |
54.71% |
-4931.56% |
- |
-43.41% |
Assertio Holdings inc |
1 Q |
88.52% |
24.81% |
67.27% |
3.21% |
Athersys Inc |
1 Q |
- |
0% |
-536.06% |
0% |
180 Life Sciences Corp. |
1 Q |
- |
- |
- |
-8.54% |
Actinium Pharmaceuticals Inc |
1 Q |
- |
-545.64% |
-618.09% |
-32.44% |
Athenex Inc |
1 Q |
21.63% |
-60.33% |
-148.04% |
-215.36% |
Adhera Therapeutics Inc. |
1 Q |
- |
- |
- |
- |
Avenue Therapeutics inc. |
1 Q |
- |
- |
- |
-439.43% |
Astria Therapeutics inc |
1 Q |
- |
- |
- |
-51.74% |
Aurinia Pharmaceuticals Inc |
1 Q |
98.82% |
-174.01% |
-459.46% |
-43.2% |
Avadel Pharmaceuticals Plc |
1 Q |
- |
- |
- |
-102.82% |
Aveo Pharmaceuticals Inc |
1 Q |
88.37% |
-48.75% |
15.79% |
-85.29% |
Atea Pharmaceuticals Inc |
1 Q |
- |
- |
- |
7.54% |
Aerovate Therapeutics Inc. |
1 Q |
- |
- |
- |
-8.86% |
Avalo Therapeutics Inc |
1 Q |
38.62% |
-1879.88% |
-1369.74% |
38.54% |
Axsome Therapeutics Inc |
1 Q |
- |
- |
- |
-389.74% |
Astrazeneca Plc |
4 Q |
66.76% |
0.31% |
16.91% |
0.29% |
Bridgebio Pharma Inc |
1 Q |
- |
-11884.89% |
-1308.85% |
- |
Atreca inc |
1 Q |
- |
- |
- |
-65.05% |
Bicycle Therapeutics Plc |
1 Q |
- |
-714.09% |
-811.11% |
-31.61% |
Biodelivery Sciences International Inc |
4 Q |
84% |
- |
31.51% |
63.64% |
Biofrontera Inc |
1 Q |
- |
30.12% |
-11.47% |
0% |
Beigene Ltd |
1 Q |
78.72% |
-141.63% |
-9.27% |
-40.1% |
Bausch Health Companies Inc |
1 Q |
71.69% |
-3.44% |
17.78% |
- |
Biohaven Pharmaceutical Holding Company Ltd |
1 Q |
91.74% |
-36.66% |
0.01% |
- |
Biovie Inc |
1 Q |
- |
- |
- |
174.44% |
Bioxytran Inc. |
1 Q |
- |
- |
- |
- |
Bellicum Pharmaceuticals Inc |
1 Q |
- |
-54014.29% |
-45621.43% |
-155.67% |
Bellerophon Therapeutics inc |
1 Q |
- |
- |
- |
-76.59% |
Biolinerx Ltd |
4 Q |
- |
- |
- |
-39.73% |
Biomea Fusion Inc. |
1 Q |
- |
- |
- |
-28.27% |
Biomerica Inc |
1 Q |
21.84% |
-1.36% |
38.83% |
-156.03% |
Biomarin Pharmaceutical Inc |
1 Q |
77.48% |
23.26% |
3.5% |
0.92% |
Bristol myers Squibb Company |
1 Q |
78.79% |
11.01% |
-14.91% |
17.68% |
Benitec Biopharma Inc. |
1 Q |
- |
-6822.92% |
-7706.25% |
-127.37% |
Blueprint Medicines Corporation |
1 Q |
9.68% |
-167.79% |
-273.14% |
-58.75% |
Bespoke Extracts Inc. |
1 Q |
72.33% |
-31770.47% |
-1760.73% |
- |
Biospecifics Technologies Corp |
3 Q |
- |
47.86% |
-124.36% |
13.39% |
Bioxcel Therapeutics Inc |
1 Q |
- |
- |
- |
-52.26% |
Beyondspring Inc |
4 Q |
- |
-5048.7% |
-5026.79% |
-326% |
Calithera Biosciences Inc |
1 Q |
- |
- |
- |
-266.85% |
Can fite Biopharma Ltd |
4 Q |
- |
-1175.26% |
-454.63% |
-69.71% |
Cymabay Therapeutics Inc |
1 Q |
- |
- |
- |
-92.27% |
Chemocentryx Inc |
1 Q |
98.12% |
-353.62% |
-86.11% |
-47.24% |
Avid Bioservices Inc. |
1 Q |
22.37% |
- |
-76.19% |
156.25% |
Celularity Inc |
1 Q |
92.01% |
-1059.26% |
- |
-105.6% |
Chembio Diagnostics Inc |
1 Q |
19.09% |
-46.72% |
-23.24% |
-123.38% |
Contrafect Corporation |
1 Q |
- |
- |
- |
-74.27% |
Chiasma Inc |
1 Q |
96.52% |
-1587.73% |
- |
-113.57% |
Checkpoint Therapeutics inc |
1 Q |
- |
-32400% |
-25498.08% |
-222.54% |
Clene Inc |
1 Q |
- |
-44513.33% |
-124526.67% |
- |
Cellectar Biosciences Inc |
1 Q |
- |
- |
- |
-67.56% |
Clearside Biomedical Inc |
1 Q |
- |
-2202.88% |
- |
0.31% |
Celsion Corporation |
1 Q |
- |
-8379.47% |
- |
-41.93% |
Clever Leaves Holdings Inc |
1 Q |
39.01% |
-308.96% |
- |
-20.07% |
Clovis Oncology inc |
1 Q |
76.44% |
-175.69% |
-61.87% |
- |
Chemomab Therapeutics Ltd |
1 Q |
- |
- |
- |
25.18% |
Compass Pathways Plc |
1 Q |
- |
- |
- |
-25.75% |
Chimerix inc. |
1 Q |
-660% |
-165113.33% |
- |
-118.41% |
Concert Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-170.61% |
Cns Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-25.94% |
Constellation Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-33.12% |
Centessa Pharmaceuticals Plc |
1 Q |
- |
- |
- |
-10.35% |
Context Therapeutics Inc |
1 Q |
- |
- |
- |
0% |
Cogent Biosciences Inc |
1 Q |
- |
- |
- |
-44.91% |
Collegium Pharmaceutical inc |
1 Q |
40.75% |
-10.98% |
-66.99% |
18.95% |
Corcept Therapeutics Inc |
1 Q |
98.67% |
24.33% |
-16.82% |
24.23% |
China Pharma Holdings Inc |
1 Q |
-10.56% |
-64.18% |
-71.34% |
-59.21% |
Cumberland Pharmaceuticals Inc |
1 Q |
80.21% |
-12.55% |
-87.46% |
-11.58% |
Catalyst Pharmaceuticals Inc |
1 Q |
86.33% |
30.73% |
16.08% |
22.12% |
Corbus Pharmaceuticals Holdings Inc |
1 Q |
- |
- |
- |
-54.78% |
Cormedix Inc |
1 Q |
80% |
-92118.83% |
-103862.83% |
-41.7% |
Crinetics Pharmaceuticals Inc |
1 Q |
- |
-1105.94% |
-1761.32% |
-46.36% |
Corvus Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-44.21% |
Cti Biopharma Corp |
1 Q |
87.89% |
-1619.83% |
- |
-616.49% |
Innovation Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-111.74% |
Catalent Inc |
1 Q |
33.23% |
11.08% |
-8.64% |
10.64% |
Cure Pharmaceutical Holding Corp. |
1 Q |
68% |
-467% |
46.69% |
0% |
Cohbar Inc. |
1 Q |
- |
- |
- |
-17.48% |
Celyad Oncology Sa |
4 Q |
- |
- |
- |
-60.75% |
Cyclacel Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-50.16% |
Cyclerion Therapeutics Inc |
1 Q |
- |
-1825.32% |
-1805.34% |
-99.04% |
Cytokinetics Incorporated |
1 Q |
- |
-7791.38% |
- |
-164.73% |
Dar Bioscience Inc |
1 Q |
- |
- |
- |
-145.59% |
Day One Biopharmaceuticals Inc |
1 Q |
- |
- |
- |
-9.65% |
Decibel Therapeutics Inc |
1 Q |
- |
- |
- |
-37.06% |
Journey Medical Corporation |
1 Q |
64.79% |
-5.92% |
-33.27% |
-127.12% |
Dice Therapeutics Inc |
1 Q |
- |
- |
- |
0% |
Diamedica Therapeutics Inc |
1 Q |
- |
- |
- |
-35.43% |
Dermata Therapeutics Inc |
1 Q |
- |
- |
- |
-37.22% |
Dicerna Pharmaceuticals Inc |
3 Q |
- |
-27.12% |
-88.09% |
-103.08% |
Durect Corp |
1 Q |
82.51% |
-566.16% |
-21.1% |
-60.89% |
Design Therapeutics Inc |
1 Q |
- |
- |
- |
-11.2% |
Dynavax Technologies Corp |
1 Q |
64.94% |
28.83% |
-225.26% |
63.02% |
Edesa Biotech Inc |
1 Q |
- |
- |
- |
-123.27% |
Effector Therapeutics Inc |
1 Q |
- |
- |
- |
188.89% |
Zyla Life Sciences |
1 Q |
81.66% |
-95.66% |
-95.86% |
-234.08% |
Eagle Pharmaceuticals inc |
1 Q |
78.27% |
38.02% |
-24.28% |
18.56% |
Elanco Animal Health Inc |
1 Q |
58.45% |
3.92% |
-24.16% |
-4.71% |
Eledon Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-21.43% |
Elite Pharmaceuticals Inc. |
1 Q |
45.05% |
31.66% |
16.25% |
40.81% |
Eliem Therapeutics Inc. |
1 Q |
- |
- |
- |
-11.79% |
Endo International Plc |
1 Q |
58.11% |
-11.03% |
-5.58% |
- |
Enlivex Therapeutics Ltd |
4 Q |
- |
- |
- |
-17.01% |
Enochian Biosciences Inc |
1 Q |
- |
- |
- |
-24.27% |
Ensysce Biosciences Inc |
1 Q |
- |
-157.67% |
-634.02% |
- |
Enanta Pharmaceuticals Inc |
1 Q |
- |
-179.48% |
-310.32% |
-28.8% |
Enveric Biosciences Inc |
1 Q |
- |
- |
- |
-166.21% |
Evolus Inc |
1 Q |
61.05% |
-51.61% |
-116.74% |
-80.2% |
Essa Pharma inc |
4 Q |
- |
-12198.22% |
-22480.56% |
-28.02% |
Epizyme Inc |
1 Q |
69.68% |
-638.28% |
-240.51% |
-1287.29% |
Eqrx Inc |
1 Q |
- |
- |
- |
2.67% |
Erasca Inc |
3 Q |
- |
- |
- |
- |
Esperion Therapeutics Inc |
1 Q |
- |
-301.18% |
-310.72% |
- |
Eton Pharmaceuticals Inc. |
1 Q |
67% |
-244.94% |
37.82% |
-73.59% |
Entasis Therapeutics Holdings Inc |
1 Q |
- |
- |
- |
-145.48% |
Evofem Biosciences Inc |
1 Q |
74.92% |
-752.03% |
-137.76% |
- |
Evoke Pharma Inc |
1 Q |
- |
-519.54% |
-345.02% |
-199.81% |
Edgewise Therapeutics inc |
1 Q |
- |
- |
- |
0% |
Fortress Biotech Inc |
1 Q |
65.71% |
-206.8% |
-76.21% |
-85.54% |
Forte Biosciences Inc. |
1 Q |
- |
- |
- |
-44.47% |
Fibrogen Inc |
1 Q |
93.03% |
-103.91% |
24.12% |
-109.09% |
Foghorn Therapeutics Inc |
1 Q |
- |
-686.58% |
- |
-118.78% |
Flexion Therapeutics Inc |
3 Q |
82.52% |
-142.14% |
- |
- |
Fresenius Medical Care Ag and Co Kgaa |
4 Q |
28.82% |
6.92% |
6.14% |
8.72% |
Amicus Therapeutics inc |
1 Q |
90.37% |
-108.31% |
-14.78% |
-95.05% |
Five Prime Therapeutics Inc |
4 Q |
- |
- |
- |
-54.86% |
F star Therapeutics Inc |
1 Q |
- |
-473.81% |
-381.65% |
-35.82% |
Fitlife Brands Inc |
3 Q |
43.92% |
16.78% |
2.86% |
46.29% |
Fulcrum Therapeutics Inc |
1 Q |
- |
-1000.31% |
-80.98% |
-48.38% |
First Wave Biopharma Inc. |
1 Q |
- |
- |
- |
- |
Galectin Therapeutics Inc. |
1 Q |
- |
- |
- |
-857.75% |
Gain Therapeutics inc |
1 Q |
- |
-7271.57% |
-5649.26% |
-40.43% |
Generation Bio Co |
1 Q |
- |
- |
- |
-32.65% |
Gb Sciences Inc |
1 Q |
- |
- |
- |
- |
Global Blood Therapeutics Inc |
1 Q |
98.09% |
-147.61% |
-531% |
-129.74% |
Geron Corp |
1 Q |
- |
-24469.92% |
-2883.74% |
-85.84% |
Guardion Health Sciences Inc |
4 Q |
40.48% |
-552.63% |
20.17% |
-69.84% |
Galmed Pharmaceuticals Ltd |
4 Q |
- |
- |
- |
106.46% |
Galapagos Nv |
4 Q |
99.66% |
-21.29% |
0% |
-3.91% |
Gelesis Holdings Inc |
1 Q |
34.62% |
-77.07% |
74.37% |
- |
Galecto Inc |
1 Q |
- |
- |
- |
-45.22% |
Glycomimetics Inc |
1 Q |
- |
- |
- |
-55.48% |
Gemini Therapeutics Inc |
1 Q |
- |
- |
- |
-50.88% |
Generex Biotechnology Corp |
1 Q |
-218.89% |
- |
- |
- |
Genprex Inc |
1 Q |
- |
- |
- |
-44% |
Graybug Vision Inc |
1 Q |
- |
- |
- |
-50.75% |
Gracell Biotechnologies Inc |
4 Q |
- |
- |
- |
-24.72% |
Grifols Sa |
4 Q |
- |
- |
- |
3.63% |
Glaxosmithkline Plc |
4 Q |
65.99% |
14.94% |
12.53% |
23.88% |
Globestar Therapeutics Corporation |
1 Q |
- |
- |
- |
- |
Gt Biopharma Inc. |
1 Q |
- |
- |
- |
-165.24% |
Gw Pharmaceuticals Plc |
1 Q |
92.26% |
-12.91% |
-18.79% |
-2.83% |
Hutchmed china Limited |
4 Q |
35.57% |
-46.9% |
79.02% |
-16.07% |
Hcw Biologics Inc |
1 Q |
57.4% |
-65.99% |
- |
-6.26% |
Hepion Pharmaceuticals inc |
1 Q |
- |
- |
- |
-34.19% |
Humanigen inc |
1 Q |
- |
-2053.86% |
-103.09% |
- |
Hookipa Pharma inc. |
1 Q |
- |
-1243.46% |
- |
-63.59% |
Hoth Therapeutics Inc |
1 Q |
- |
- |
- |
-105.89% |
Werewolf Therapeutics Inc |
1 Q |
- |
- |
- |
-36.02% |
Health right Discoveries Inc |
3 Q |
81.21% |
-121.6% |
-69.65% |
- |
Harmony Biosciences Holdings inc |
1 Q |
82.75% |
25.18% |
-11.5% |
28.66% |
Harrow Health Inc |
1 Q |
73.04% |
-11.02% |
-0.99% |
-138.33% |
Heron Therapeutics Inc |
1 Q |
51.59% |
-272.36% |
-143.37% |
-243.86% |
Histogen Inc |
1 Q |
- |
-18.22% |
-22.29% |
-54.31% |
Horizon Therapeutics Public Limited Company |
1 Q |
75.71% |
23.07% |
7.13% |
19.14% |
Ibio inc |
4 Q |
32.74% |
-7095.24% |
-10520.83% |
-28.09% |
Intercept Pharmaceuticals inc |
1 Q |
99.14% |
-19.51% |
-39.44% |
- |
Ideaya Biosciences Inc |
1 Q |
- |
-123.36% |
-323.58% |
-19.08% |
I mab |
4 Q |
47.25% |
-2648.74% |
-1403.18% |
-51.14% |
Immunogen inc |
1 Q |
- |
-63.41% |
-107.91% |
-66.56% |
Imago Biosciences Inc |
1 Q |
- |
- |
- |
-11.74% |
Immutep Ltd |
2 Q |
- |
-753.57% |
- |
-40.81% |
Immunome inc |
2 Q |
- |
- |
- |
-40.28% |
Impel Pharmaceuticals Inc. |
1 Q |
41.27% |
-1533.26% |
- |
-178.04% |
Imara inc |
1 Q |
- |
- |
- |
-59.32% |
Immuron Limited |
2 Q |
64.97% |
-5751.61% |
- |
-32.38% |
Immuneering Corp |
1 Q |
50.55% |
-7020.42% |
- |
-12.19% |
Immunic Inc |
1 Q |
- |
- |
- |
-59.64% |
Indaptus Therapeutics Inc |
4 Q |
- |
- |
- |
0% |
Inmed Pharmaceuticals Inc |
1 Q |
58.88% |
-1122.69% |
-1738.34% |
0% |
Insmed Inc |
1 Q |
77.04% |
-178.17% |
-378.63% |
-111.77% |
Inspire Medical Systems inc |
1 Q |
85.58% |
-24.06% |
-16.11% |
-19.02% |
Innoviva Inc |
1 Q |
- |
42.04% |
16.96% |
60.5% |
Inozyme Pharma Inc |
1 Q |
- |
- |
- |
-53.41% |
Io Biotech Inc. |
1 Q |
- |
- |
- |
0% |
Ionis Pharmaceuticals Inc |
1 Q |
97.06% |
-45.92% |
-230.19% |
-0.6% |
Intellipharmaceutics International Inc |
4 Q |
- |
-241.95% |
9.81% |
- |
Ironwood Pharmaceuticals inc |
1 Q |
- |
39.78% |
-27.44% |
122.32% |
Iveric Bio Inc |
1 Q |
- |
- |
- |
-46.15% |
Intra cellular Therapies Inc |
1 Q |
- |
-206.08% |
- |
-53.93% |
Jaguar Health inc |
1 Q |
82.67% |
-691.96% |
15.43% |
-320.63% |
Janux Therapeutics Inc |
1 Q |
- |
-843.93% |
- |
-3.61% |
Jazz Pharmaceuticals Plc |
4 Q |
- |
-51.45% |
-58.56% |
-23.6% |
Johnson and Johnson |
1 Q |
67.57% |
21.98% |
-17.18% |
27.49% |
Kala Pharmaceuticals inc. |
1 Q |
- |
-2400.95% |
-2114.29% |
-369.16% |
Kalvista Pharmaceuticals Inc |
4 Q |
- |
- |
- |
-31.24% |
Kyto Technology And Life Science Inc |
4 Q |
- |
- |
- |
13.86% |
Kadmon holdings inc |
3 Q |
95.63% |
-232.46% |
47.23% |
-216.92% |
Chinook Therapeutics Inc |
1 Q |
- |
-1174.79% |
-2900.41% |
-26.93% |
Kindred Biosciences Inc |
2 Q |
81.93% |
-258.07% |
- |
-54.55% |
Kamada Ltd |
4 Q |
29.26% |
-2.15% |
0% |
-1.26% |
Kempharm Inc |
1 Q |
- |
-47.01% |
-306.03% |
-0.1% |
Kiniksa Pharmaceuticals Ltd |
1 Q |
86.89% |
-78.32% |
-183.75% |
-66.73% |
Kinnate Biopharma Inc |
1 Q |
- |
- |
- |
-8.17% |
Kiora Pharmaceuticals inc |
4 Q |
- |
- |
- |
-131.92% |
Karyopharm Therapeutics Inc |
1 Q |
- |
-86.84% |
-89.24% |
- |
Kronos Bio Inc |
1 Q |
- |
- |
- |
-43.43% |
Keros Therapeutics Inc |
1 Q |
- |
- |
- |
-29.12% |
Karuna Therapeutics Inc |
1 Q |
- |
- |
- |
-33.73% |
Kintara Therapeutics Inc |
1 Q |
- |
- |
- |
-721.02% |
Pasithea Therapeutics Corp. |
1 Q |
5.28% |
-11526.14% |
-19369.6% |
0% |
Kura Oncology Inc |
1 Q |
- |
- |
- |
-25.49% |
Khosla Ventures Acquisition Co |
1 Q |
- |
- |
- |
- |
Landos Biopharma Inc |
1 Q |
- |
- |
- |
-51.46% |
Longboard Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-29.74% |
Lannett Company Inc |
1 Q |
3.93% |
-44.54% |
9.54% |
- |
Legend Biotech Corporation |
4 Q |
- |
-430.12% |
- |
-81.96% |
Lexaria Bioscience Corp |
1 Q |
79.16% |
-4651.8% |
-8347.22% |
-34.81% |
Lifevantage Corp |
1 Q |
80.69% |
2.28% |
-4.76% |
26.43% |
Ligand Pharmaceuticals Incorporated |
1 Q |
74.15% |
-33.67% |
-9.91% |
2.94% |
Longeveron Inc |
1 Q |
81.08% |
-948.65% |
-952.97% |
-11.82% |
Lianbio |
1 Q |
- |
- |
- |
0% |
Lftd Partners Inc |
1 Q |
44.14% |
16.28% |
16.48% |
30.2% |
Eli Lilly And Company |
1 Q |
73.47% |
24.36% |
-17.4% |
73.77% |
Liminal Biosciences Inc |
4 Q |
- |
- |
- |
36.05% |
Lipocine Inc |
1 Q |
- |
- |
- |
-1.93% |
Leap Therapeutics inc |
1 Q |
- |
- |
- |
-47.38% |
Larimar Therapeutics Inc |
1 Q |
- |
- |
- |
-72.75% |
Lantern Pharma Inc |
1 Q |
- |
- |
- |
0% |
Lumos Pharma Inc |
1 Q |
- |
-6954.95% |
-7253.15% |
-32.26% |
Lexicon Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-75.21% |
Lyell Immunopharma Inc |
1 Q |
- |
-12322.6% |
-12914.83% |
-7.14% |
Merrimack Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-20.89% |
Marizyme Inc. |
1 Q |
- |
- |
- |
-28.8% |
Mustang Bio inc |
4 Q |
- |
- |
- |
-68.56% |
Moleculin Biotech Inc |
1 Q |
- |
- |
- |
-23.07% |
Seres Therapeutics Inc |
1 Q |
- |
-3792.63% |
-1783.32% |
-70.91% |
Medavail Holdings Inc |
1 Q |
5.5% |
-142.88% |
-155.13% |
-191.44% |
23andme Holding Co. |
1 Q |
46.8% |
-69.16% |
-32.84% |
-27.2% |
Mei Pharma Inc. |
3 Q |
- |
-225.73% |
91.25% |
-112.21% |
Macrogenics Inc |
1 Q |
99.57% |
-598.53% |
-685.89% |
-84.52% |
Magenta Therapeutics Inc. |
1 Q |
- |
- |
- |
-42.77% |
Mirum Pharmaceuticals Inc |
1 Q |
- |
-283.94% |
- |
-73.5% |
Milestone Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-36.93% |
Stealth Biotherapeutics Corp |
4 Q |
- |
- |
- |
- |
Moonlake Immunotherapeutics |
1 Q |
- |
- |
- |
-61.8% |
Mallinckrodt Plc |
1 Q |
35.79% |
-24.36% |
4.18% |
- |
Mannkind Corporation |
1 Q |
27.33% |
-216.79% |
-474.82% |
- |
Mallinckrodt Plc |
1 Q |
35.79% |
-24.36% |
4.18% |
-154.21% |
Medicinova Inc |
1 Q |
- |
- |
- |
-15.7% |
Monopar Therapeutics Inc |
1 Q |
- |
- |
- |
-12.2% |
Morphosys Ag |
4 Q |
82.08% |
-286.43% |
61.13% |
-210.09% |
Morphic Holding inc |
1 Q |
- |
-1321.75% |
-2165.91% |
-31.37% |
Mereo Biopharma Group Plc |
4 Q |
50.89% |
34.9% |
64.36% |
14.46% |
Merck and Co Inc |
1 Q |
66.17% |
27.12% |
2.81% |
38.23% |
Marker Therapeutics inc |
1 Q |
- |
-1027.72% |
-1522.13% |
-88.13% |
Marinus Pharmaceuticals Inc |
1 Q |
91.76% |
-136.48% |
23.91% |
-136.1% |
Mersana Therapeutics inc |
1 Q |
- |
-2321.12% |
- |
-119.1% |
Mirati Therapeutics Inc |
1 Q |
- |
-26570.66% |
-15287.31% |
-52.23% |
Maravai Lifesciences Holdings Inc |
1 Q |
83.61% |
60.12% |
-49.04% |
108.79% |
Metacrine Inc |
1 Q |
- |
- |
- |
-112.65% |
Molecular Templates Inc |
1 Q |
- |
- |
-75.55% |
110.16% |
Midatech Pharma Plc |
4 Q |
- |
-944.64% |
0% |
-52.24% |
Mylan N v |
3 Q |
38.98% |
6.25% |
11.52% |
2.25% |
Myovant Sciences Ltd |
1 Q |
93.72% |
-102.98% |
-88.66% |
- |
Nature s Sunshine Products inc |
1 Q |
68.81% |
-2.43% |
-17.78% |
15.43% |
Nabriva Therapeutics Plc |
1 Q |
58.09% |
-147.37% |
-173.02% |
-82.07% |
Neubase Therapeutics inc |
1 Q |
- |
- |
- |
-70.88% |
Nanobiotix S a |
4 Q |
- |
-1775.71% |
- |
-175.45% |
Novabay Pharmaceuticals Inc |
1 Q |
57.66% |
-4.22% |
-83.15% |
-36.44% |
Nucana Plc |
4 Q |
- |
- |
- |
-61.84% |
Neos Therapeutics Inc |
3 Q |
59.15% |
-39.18% |
0.52% |
- |
Neptune Wellness Solutions Inc |
1 Q |
-6.22% |
-205.77% |
33.2% |
-42.37% |
Minerva Neurosciences inc |
1 Q |
- |
- |
- |
-284.62% |
Neximmune Inc |
1 Q |
- |
- |
- |
-63.55% |
Ngm Biopharmaceuticals Inc |
1 Q |
- |
-154.91% |
-200.13% |
-36.46% |
Nighthawk Biosciences inc. |
1 Q |
- |
-3855.51% |
- |
-30.54% |
Nektar Therapeutics |
1 Q |
78.59% |
-364.16% |
- |
-65.63% |
Nkarta Inc |
1 Q |
- |
- |
- |
-35.72% |
9 Meters Biopharma Inc. |
1 Q |
- |
- |
- |
-94.39% |
Nanomix Corp |
1 Q |
- |
- |
- |
- |
Novan Inc. |
1 Q |
89.32% |
-693.98% |
-601.3% |
-165.01% |
Neurobo Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-140.86% |
Nurix Therapeutics Inc |
1 Q |
- |
-442.09% |
-11.55% |
-38.11% |
Nrx Pharmaceuticals Inc. |
1 Q |
- |
- |
- |
-3283.94% |
Rebus Holdings Inc |
1 Q |
- |
- |
- |
- |
Intec Pharma Ltd |
1 Q |
- |
- |
- |
-96.37% |
Neurotrope inc |
3 Q |
- |
- |
- |
46.07% |
Nuvation Bio Inc |
1 Q |
- |
- |
- |
-11.59% |
Novartis Ag |
4 Q |
69.99% |
45.42% |
18.27% |
35.41% |
Northwest Biotherapeutics inc |
1 Q |
- |
-3527.05% |
-2036.23% |
- |
Nextcure Inc |
1 Q |
- |
- |
- |
-30.63% |
Obseva Sa |
4 Q |
- |
-290.25% |
- |
-180.52% |
Ocular Therapeutix Inc |
1 Q |
90.14% |
-95.11% |
-142.16% |
-26.5% |
Ocuphire Pharma Inc |
1 Q |
- |
- |
- |
-117.53% |
Oragenics Inc |
1 Q |
- |
-40014.55% |
-39072.07% |
-61.04% |
Organon and Co |
1 Q |
64.2% |
22.21% |
-2.74% |
- |
Olema Pharmaceuticals inc |
1 Q |
- |
- |
- |
-27.06% |
Omeros Corporation |
1 Q |
- |
- |
- |
- |
Oncorus Inc |
1 Q |
- |
- |
- |
-50.39% |
Oncosec Medical Incorporated |
1 Q |
- |
- |
- |
-150.2% |
Oncolytics Biotech Inc |
4 Q |
- |
- |
- |
-72.87% |
Onconova Therapeutics inc |
4 Q |
- |
-2076.6% |
- |
-53.42% |
Opko Health Inc |
1 Q |
32.81% |
-16.84% |
-9.85% |
-6.85% |
Optinose Inc |
1 Q |
86.36% |
-171.63% |
-129.65% |
- |
Organogenesis Holdings Inc |
1 Q |
74.44% |
0.09% |
-6.14% |
39.86% |
Oric Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-31.74% |
Oramed Pharmaceuticals Inc |
1 Q |
- |
- |
76.73% |
25.72% |
Orphazyme A |
4 Q |
- |
-1731.11% |
- |
-100.97% |
Otonomy Inc |
1 Q |
- |
- |
- |
-86.69% |
Oncotelic Therapeutics Inc |
4 Q |
- |
- |
- |
-113.41% |
Ovid Therapeutics Inc |
1 Q |
- |
-1114.46% |
-1461.88% |
-38.63% |
Phibro Animal Health Corp |
1 Q |
29.89% |
7.38% |
3.07% |
24.05% |
Pandion Therapeutics Inc |
4 Q |
- |
- |
- |
0% |
Prestige Consumer Healthcare Inc |
1 Q |
55.77% |
-55.97% |
2.31% |
13.75% |
Panbela Therapeutics Inc |
1 Q |
- |
- |
- |
-127.71% |
Puma Biotechnology Inc |
1 Q |
76.29% |
-7.44% |
-17.64% |
-844.14% |
Pacira Biosciences inc |
1 Q |
77.17% |
4.32% |
-227.12% |
5.4% |
Processa Pharmaceuticals Inc. |
1 Q |
- |
- |
- |
-42.39% |
Pds Biotechnology Corp |
1 Q |
- |
- |
- |
-34.38% |
Pfizer Inc |
1 Q |
61.09% |
30.67% |
2.06% |
32.65% |
Pfenex Inc |
2 Q |
12.93% |
-1322.79% |
-584.64% |
-11.41% |
Progenics Pharmaceuticals Inc |
1 Q |
75.06% |
-268.9% |
-206.16% |
-129.46% |
Pharming Group N v |
4 Q |
89.37% |
8.04% |
- |
8.29% |
Phasebio Pharmaceuticals Inc. |
1 Q |
- |
-9522.22% |
-19753.85% |
- |
Phio Pharmaceuticals Corp |
1 Q |
- |
- |
- |
-52.46% |
Pharvaris N v |
4 Q |
- |
- |
- |
-20.85% |
Pliant Therapeutics Inc |
1 Q |
- |
-2249.8% |
-1530.82% |
-48.97% |
Plx Pharma Inc |
1 Q |
43.88% |
-517.76% |
-810.99% |
-130.17% |
Pmv Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-20.48% |
Point Biopharma Global Inc |
1 Q |
- |
- |
- |
-31.55% |
One World Products Inc. |
1 Q |
1.88% |
-5942.25% |
-337.76% |
- |
Purple Biotech Ltd |
4 Q |
- |
- |
- |
28.37% |
Propanc Biopharma Inc. |
1 Q |
- |
- |
- |
- |
Praxis Precision Medicines Inc |
1 Q |
- |
- |
- |
-77.8% |
Pardes Biosciences Inc |
1 Q |
- |
- |
- |
-16.86% |
Perrigo Company Plc |
1 Q |
31.44% |
-0.22% |
8.02% |
2.85% |
Principia Biopharma Inc |
2 Q |
- |
21.62% |
- |
0% |
Prophase Labs Inc |
1 Q |
60.33% |
26.29% |
36.08% |
32.04% |
Proqr Therapeutics N v |
4 Q |
- |
- |
- |
0% |
Prothena Corporation Public Limited Company |
1 Q |
- |
-3147.44% |
-3130.96% |
16.02% |
Paratek Pharmaceuticals Inc |
1 Q |
85.95% |
-72.04% |
-125.53% |
- |
Provention Bio Inc |
1 Q |
- |
-3787.59% |
-565.52% |
-83.66% |
Ptc Therapeutics inc |
1 Q |
- |
-85.2% |
-30.62% |
-983.21% |
Portola Pharmaceuticals inc |
1 Q |
83.63% |
-260.6% |
-68.57% |
-273.08% |
Palatin Technologies Inc |
1 Q |
78.29% |
-3531.56% |
-4445.23% |
-95.87% |
Provectus Biopharmaceuticals Inc. |
1 Q |
- |
-549.52% |
-333.64% |
- |
Pyxis Oncology Inc |
1 Q |
- |
- |
- |
0% |
Qualigen Therapeutics Inc |
1 Q |
- |
-598.28% |
-543.94% |
-139.46% |
Uniqure N v |
1 Q |
- |
-2604.8% |
-1745.2% |
54.85% |
Rain Therapeutics Inc |
1 Q |
- |
- |
- |
-44.51% |
Rani Therapeutics Holdings Inc |
1 Q |
- |
- |
- |
-15.2% |
Ultragenyx Pharmaceutical Inc |
1 Q |
92.37% |
-190.55% |
-191.88% |
-51.89% |
Rasna Therapeutics Inc. |
1 Q |
- |
- |
- |
- |
Rocket Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-37.21% |
Redhill Biopharma Ltd |
4 Q |
42.39% |
- |
34.16% |
1101.34% |
Radius Health inc |
1 Q |
90.13% |
-42.35% |
-92.49% |
- |
Dr Reddys Laboratories Ltd |
1 Q |
53.08% |
11% |
0% |
13.14% |
Regeneron Pharmaceuticals Inc |
1 Q |
93.01% |
32.83% |
15.55% |
44.65% |
Reliv International Inc |
3 Q |
73.58% |
-1.44% |
7.03% |
-1.53% |
Reata Pharmaceuticals Inc |
1 Q |
- |
-8078.99% |
-6376.26% |
-137.52% |
Revelation Biosciences Inc. |
1 Q |
- |
- |
- |
- |
Regulus Therapeutics Inc |
1 Q |
- |
- |
- |
-77.06% |
Rigel Pharmaceuticals Inc |
1 Q |
99.28% |
-164% |
34.59% |
-219.06% |
Rallybio Corporation |
1 Q |
- |
- |
- |
0% |
Avidity Biosciences Inc |
1 Q |
- |
-1907.24% |
-10080% |
-36.26% |
Transcode Therapeutics Inc. |
1 Q |
- |
- |
- |
-25% |
Renovorx Inc |
1 Q |
- |
- |
- |
0% |
Roivant Sciences Ltd. |
1 Q |
- |
-2313.9% |
-896.93% |
0% |
Reneo Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-30.08% |
Repare Therapeutics Inc |
1 Q |
- |
- |
- |
-47.6% |
Rvl Pharmaceuticals Plc |
1 Q |
90% |
-31.81% |
-65.77% |
-10.13% |
Revance Therapeutics Inc |
1 Q |
56.01% |
-254.71% |
- |
-483.19% |
Reviva Pharmaceuticals Holdings Inc. |
1 Q |
- |
- |
- |
-51.14% |
Prometheus Biosciences Inc |
1 Q |
- |
-818.22% |
-771.12% |
-43.92% |
Rhythm Pharmaceuticals inc |
4 Q |
87.01% |
-2359.16% |
-1823% |
-20.79% |
Rezolute Inc |
1 Q |
- |
- |
- |
-94.24% |
Sage Therapeutics Inc |
1 Q |
81.92% |
-7715.23% |
-7304.61% |
-27.23% |
Cassava Sciences Inc |
1 Q |
- |
- |
- |
-17.93% |
Silverback Therapeutics Inc |
1 Q |
- |
- |
- |
-29.56% |
Scopus Biopharma Inc |
1 Q |
- |
- |
- |
-3421.76% |
Societal Cdmo Inc |
1 Q |
23.97% |
-20.12% |
-46.9% |
-23.33% |
Scynexis inc |
1 Q |
- |
-793.45% |
-1349.93% |
-89.64% |
Seelos Therapeutics Inc |
1 Q |
- |
-53850% |
-65238.46% |
-94.26% |
Sesen Bio Inc |
1 Q |
- |
- |
- |
7.73% |
Sigilon Therapeutics Inc |
1 Q |
- |
-437.88% |
-1347.74% |
-83.44% |
Siga Technologies Inc |
1 Q |
55.21% |
-3.43% |
- |
49.46% |
Sio Gene Therapies Inc. |
1 Q |
- |
- |
- |
-82.33% |
Skye Bioscience Inc |
1 Q |
- |
- |
- |
-194.19% |
Sellas Life Sciences Group Inc |
1 Q |
89.89% |
-1693.02% |
-718.2% |
-166.08% |
Summit Therapeutics Inc |
1 Q |
- |
-8558.8% |
- |
-111.36% |
Sonoma Pharmaceuticals Inc |
4 Q |
41.45% |
-32.53% |
4.72% |
-71.16% |
Synaptogenix Inc |
1 Q |
- |
- |
- |
10.18% |
Sensei Biotherapeutics Inc |
1 Q |
- |
- |
- |
-27.48% |
Sanofi |
4 Q |
67.47% |
33.05% |
25.23% |
19.56% |
Sonnet Biotherapeutics Holdings Inc |
1 Q |
- |
-8611.52% |
-6057.69% |
-118.71% |
Spectrum Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-190.29% |
Spruce Biosciences Inc |
1 Q |
- |
- |
- |
-38.29% |
Scisparc Ltd |
4 Q |
- |
- |
- |
71.11% |
Sarepta Therapeutics Inc |
1 Q |
- |
-49.82% |
-418.34% |
-52.06% |
Sierra Oncology Inc |
1 Q |
- |
- |
- |
-76.49% |
Statera Biopharma Inc fka Cytocom Inc |
3 Q |
50.99% |
-5383.61% |
- |
-56.39% |
Stemline Therapeutics Inc |
1 Q |
92.78% |
-239.99% |
- |
-48.14% |
Stoke Therapeutics Inc |
1 Q |
- |
-821.63% |
-2026.13% |
-39.42% |
Supernus Pharmaceuticals inc |
1 Q |
88.24% |
16.8% |
-57.52% |
9.05% |
Sinovac Biotech Ltd |
4 Q |
94.47% |
74.63% |
54.55% |
104.2% |
Savara Inc |
1 Q |
- |
- |
- |
-27.33% |
Synlogic Inc |
1 Q |
- |
-6433.2% |
- |
-43.07% |
Synthetic Biologics inc. |
1 Q |
- |
- |
- |
-23.05% |
Syros Pharmaceuticals inc. |
1 Q |
- |
-459.96% |
-415.71% |
-101.54% |
Takeda Pharmaceutical Company Limited |
1 Q |
- |
- |
- |
3.62% |
Taro Pharmaceutical Industries Ltd |
1 Q |
54.04% |
-73% |
16.73% |
-23.64% |
Theravance Biopharma inc |
1 Q |
- |
-196.62% |
33.4% |
- |
Tricida Inc |
1 Q |
- |
- |
- |
- |
Alaunos Therapeutics Inc. |
1 Q |
- |
- |
- |
-101.43% |
Terns Pharmaceuticals Inc. |
1 Q |
- |
- |
- |
-30.55% |
Teva Pharmaceutical Industries Ltd |
1 Q |
47.53% |
-26% |
1.42% |
-5.24% |
Tff Pharmaceuticals Inc |
1 Q |
- |
-12420.85% |
-10944.62% |
-19.29% |
Thorne Healthtech Inc |
1 Q |
55.09% |
8.62% |
-36.03% |
0% |
Theseus Pharmaceuticals inc |
1 Q |
- |
- |
- |
0% |
Taiwan Liposome Company Ltd |
4 Q |
- |
-964.68% |
- |
-113.89% |
Teligent Inc |
2 Q |
-25.91% |
-123.32% |
-47.14% |
- |
Tiziana Life Sciences Ltd |
4 Q |
- |
- |
- |
-37.54% |
Timber Pharmaceuticals Inc |
1 Q |
- |
-3695% |
-3544.57% |
-179.6% |
Tango Therapeutics Inc |
1 Q |
- |
-437.79% |
-714.22% |
-9.74% |
Tonix Pharmaceuticals Holding Corp |
1 Q |
- |
- |
- |
-48.46% |
Tempest Therapeutics Inc |
1 Q |
- |
- |
- |
-72.31% |
Turning Point Therapeutics Inc |
1 Q |
- |
-17353.15% |
-27586.71% |
-28.04% |
Entrada Therapeutics Inc |
1 Q |
- |
- |
- |
0% |
Trillium Therapeutics Inc |
3 Q |
- |
- |
- |
15.79% |
Trevi Therapeutics inc |
1 Q |
- |
- |
- |
-232.27% |
Trevena inc |
1 Q |
-935% |
-81945% |
-91295% |
-82.39% |
2seventy Bio Inc |
1 Q |
93.94% |
-1016.86% |
- |
0% |
Titan Pharmaceuticals inc. |
1 Q |
- |
-1322.92% |
- |
-142.58% |
Tetraphase Pharmaceuticals Inc |
1 Q |
22.51% |
-690.83% |
- |
-210.86% |
Travere Therapeutics Inc |
1 Q |
95.59% |
-156.68% |
- |
-70.33% |
Therapeuticsmd Inc |
1 Q |
74.86% |
-253.56% |
-179.68% |
- |
Tyme Technologies Inc. |
1 Q |
- |
- |
- |
-26.64% |
Tyra Biosciences Inc |
1 Q |
- |
- |
- |
0% |
Unicycive Therapeutics Inc |
1 Q |
- |
- |
- |
-31.78% |
United Therapeutics Corporation |
1 Q |
94.39% |
51.94% |
-17.64% |
17.62% |
Vaccitech Plc |
1 Q |
- |
17.14% |
-89.61% |
-13.29% |
Vaxxinity Inc |
1 Q |
- |
- |
- |
0% |
Vascular Biogenics Ltd |
4 Q |
52.47% |
- |
- |
59.15% |
Vaccinex Inc. |
1 Q |
- |
- |
- |
-155.64% |
Vera Therapeutics Inc. |
1 Q |
- |
- |
- |
-47.14% |
Verve Therapeutics Inc |
1 Q |
- |
- |
- |
-8.16% |
Viela Bio Inc |
3 Q |
- |
-1625.43% |
-859.33% |
-18.16% |
Vincerx Pharma Inc |
1 Q |
- |
- |
- |
-54.69% |
Viracta Therapeutics Inc |
1 Q |
- |
- |
- |
0% |
Viking Therapeutics Inc |
1 Q |
- |
- |
- |
-27.77% |
Vallon Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-134.01% |
Vanda Pharmaceuticals Inc |
1 Q |
90.59% |
-10.68% |
24.68% |
3.65% |
Verrica Pharmaceuticals Inc |
1 Q |
- |
-1965.2% |
- |
-112.86% |
Verona Pharma Plc |
1 Q |
- |
- |
- |
-39.61% |
Virpax Pharmaceuticals Inc. |
1 Q |
- |
- |
- |
-17.26% |
Vertex Pharmaceuticals Inc |
1 Q |
88.28% |
36.33% |
38.33% |
24.67% |
Verastem Inc |
1 Q |
- |
-653.39% |
- |
-84.99% |
Viatris Inc |
1 Q |
42.25% |
9.52% |
1.22% |
0.81% |
Vtv Therapeutics Inc |
1 Q |
- |
-471.2% |
-63.85% |
- |
Ventyx Biosciences Inc |
1 Q |
- |
- |
- |
0% |
Vyne Therapeutics Inc |
1 Q |
- |
- |
- |
96.49% |
World Health Energy Holdings Inc. |
1 Q |
- |
-5029.8% |
- |
- |
Xbiotech Inc |
1 Q |
57.4% |
-1079% |
-1032.4% |
-6.99% |
Exicure Inc |
1 Q |
- |
-325.46% |
-731.15% |
-324.25% |
Xenon Pharmaceuticals Inc |
1 Q |
- |
-220.98% |
-674.73% |
-20.31% |
Xeris Biopharma Holdings Inc |
1 Q |
71.58% |
1.85% |
- |
-398.29% |
Xilio Therapeutics inc |
1 Q |
- |
- |
- |
0% |
Xencor Inc |
1 Q |
- |
27.6% |
-76.28% |
15.74% |
Xoma Corporation |
1 Q |
- |
-73.38% |
-217.06% |
23.33% |
Xtl Biopharmaceuticals Ltd |
4 Q |
- |
- |
- |
-14.66% |
Y mabs Therapeutics inc |
1 Q |
82.54% |
-267.67% |
-236.89% |
-59.67% |
Yumanity Therapeutics Inc |
1 Q |
- |
-1308.02% |
-1866.28% |
-162.54% |
Zogenix Inc |
4 Q |
93.83% |
- |
-18.63% |
-91.2% |
Zentalis Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-56.08% |
Zosano Pharma Corporation |
1 Q |
34.85% |
-25309.85% |
- |
-172.07% |
Zoetis Inc |
1 Q |
71.35% |
29.91% |
-17.62% |
45.41% |
Zynerba Pharmaceuticals Inc. |
1 Q |
- |
- |
- |
-50.04% |